Skip to main content

Appendix DAPC Study Participating Institutions and Investigators

From: Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)

Investigator Institution
Japan  
   Goto T Department of Internal Medicine, Japanese Red Cross Akita Hospital, Akita
   Imano A Department of Internal Medicine, Osaka Kouseinenkin Hospital, Osaka, Japan
   Jinnouchi H Department of Internal Medicine, Jinnouchi Hospital, Kumamoto, Japan
   Kanazawa A Department of Internal Medicine, Division of Metabolism and Endocrinology, Juntendo University School of Medicine, Tokyo, Japan
   Kasayama S Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
   Kosugi K Department of Internal Medicine, Osaka Police Hospital, Osaka, Japan
   Matsuoka T Kurashiki Life Style Disease Center, Okayama, Japan
   Nakato T Department of Internal Medicine, Okayama Saiseikai General Hospital, Okayama, Japan
   Ono T Department of Diabetes and Endocrine, Iwaki Kyoritsu Hospital, Fukushima, Japan
   Ota M Department of Comprehensive Medical Care, Ota Nishinouchi Hospital, Fukushima
   Seino H Center of Diabetes, Ota Nishinouchi Hospital, Fukushima, Japan
   Sumiya T Department of Endocrine and Diabetes, NTT West Osaka Hospital, Osaka, Japan
   Yagi M Department of Endocrinology and Metabolism, Belland General Hospital, Osaka, Japan
   Yamasaki Y* Department of Endocrine and Metabolic Internal Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
Korea  
   Chung MY Department of Internal Medicine, Chonnam National University College of Medicine, Gwangju, Korea
   Kim YS* Department of Internal Medicine, Kyunghee University College of Medicine, Seoul, Korea
   Lee HC Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
   Soon KH Department of Internal Medicine, Keimyung University College of Medicine, Daegu, Korea
   Yoon KH Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
Philippines  
   Ganzon MS Department of Vascular Medicine, Heart Institute, St. Luke’s Medical Center, Manila, Philippines
China  
   Guo X Department of Endocrinology, Peking University First Hospital, Beijing, China
  1. *Study director